Cargando…
Hepatic Radiotherapy in Addition to Anti-PD-1 for the Treatment of Metastatic Uveal Melanoma Patients
SIMPLE SUMMARY: Uveal melanoma often metastasizes to the liver. Immune checkpoint inhibitors showed low efficacy in this disease. Liver directed therapies are widely employed despite limited results. The addition of hepatic radiotherapy to anti-PD-1 could enhance the efficacy of immune checkpoint in...
Autores principales: | Rossi, Ernesto, Cellini, Francesco, Pagliara, Monica Maria, Sammarco, Maria Grazia, Pedone, Romina Rose, Lancellotta, Valentina, Tagliaferri, Luca, Quirino, Michela, Gambacorta, Maria Antonietta, Blasi, Maria Antonietta, Tortora, Giampaolo, Schinzari, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857311/ https://www.ncbi.nlm.nih.gov/pubmed/36672442 http://dx.doi.org/10.3390/cancers15020493 |
Ejemplares similares
-
Personalized re-treatment strategy for uveal melanoma local recurrences after interventional radiotherapy (brachytherapy): single institution experience and systematic literature review
por: Tagliaferri, Luca, et al.
Publicado: (2019) -
Pembrolizumab as first-line treatment for metastatic uveal melanoma
por: Rossi, Ernesto, et al.
Publicado: (2019) -
Immunological Backbone of Uveal Melanoma: Is There a Rationale for Immunotherapy?
por: Rossi, Ernesto, et al.
Publicado: (2019) -
Radiological and clinical findings in uveal melanoma treated by plaque interventional radiotherapy (brachytherapy): Visual atlas and literature review on response assessment
por: Fionda, Bruno, et al.
Publicado: (2022) -
Circulating immune profile can predict survival of metastatic uveal melanoma patients: results of an exploratory study
por: Rossi, Ernesto, et al.
Publicado: (2022)